Optimising Adherence Pilot Program: Investigating the impact of a novel intervention on the incidence of trismus during radiotherapy for head and neck cancer patients
Not Applicable
Not yet recruiting
- Conditions
- trismusMusculoskeletal - Other muscular and skeletal disordersCancer - Head and neckhead and neck cancerOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
- Registration Number
- ACTRN12622001270707
- Lead Sponsor
- Chris O'Brien Lifehouse
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
• 18 years and older
• Diagnosis of head and neck cancer (HNC)
• Planned for radiotherapy to treat HNC
• Willingness to give informed consent
Exclusion Criteria
Patients where trismus therapy is contraindicated due to medical/surgical parameters, guided by their managing physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method